Discover 3,059 paid clinical trials in Pennsylvania. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Pennsylvania provides numerous options to healthy volunteers looking to take part in paid research studies, as well as participants looking for condition-specific trials. Research hubs in Philadelphia, Pittsburgh, and Allentown are actively recruiting participants, giving access to groundbreaking treatments and quality healthcare.
Filter
1
Filter results
Results: 3,059
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
for
Heart Failure, Acute Heart Failure
Location: Boston MA, Providence RI, Stony Brook NY, Sherbrooke,
Sponsor: Colorado Prevention Center
Sex: All
Age: 18+
Code: NCT06008197
Phase 3, Recruiting
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
for
Chronic Migraine
Location: Nashua NH, Philadelphia PA, Miami FL, Weston FL,
Sponsor: AbbVie
Sex: All
Age: 12 - 17
Code: NCT06810505
Phase 3, Recruiting
Clinical Responsiveness of Dermatomyositis Using Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI)
for
Dermatomyositis
Location: Philadelphia PA
Sponsor: University of Pennsylvania
Sex: All
Age: 18+
Code: NCT02945345
Recruiting
Early Antenatal Support for Iron Deficiency Anemia
for
Pregnancy Related, Anemia, Iron Deficiency, Anemia of Pregnancy
Location: Philadelphia PA
Sponsor: Thomas Jefferson University
Sex: Female
Age: 18 - 65
Code: NCT04278651
Recruiting
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
for
Moderately to Severely Active Crohn Disease
Location: New Bedford MA, Miami FL, Roanoke VA, Uniontown PA,
Sponsor: Abivax S.A.
Sex: All
Age: 18 - 70+
Code: NCT06456593
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
Effectiveness of Aurix Therapy in Venous Leg Ulcers
for
Venous Leg Ulcers
Location: Boston MA, Bristol CT, Middletown NY, Harris NY,
Sponsor: Nuo Therapeutics
Sex: All
Age: 18+
Code: NCT02352454
Recruiting
DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)
for
Glioblastoma (GBM)
Location: Boston MA, New York NY, Summit NJ, New Brunswick NJ,
Sponsor: Diakonos Oncology Corporation
Sex: All
Age: 18+
Code: NCT06805305
Phase 2, Recruiting
Molecular Genetics Studies of Cancer Patients and Their Relatives
for
Malignant Neoplasm
Location: Brighton MA, Mount Kisco NY, Poughkeepsie NY,
Sponsor: City of Hope Medical Center
Sex: All
Age: 0+
Code: NCT04185935
Recruiting
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC
for
Non-squamous Non-small Cell Lung Cancer
Location: Saint John, South Portland ME, West Haven CT,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06627647
Phase 3, Recruiting
Abatacept for the Treatment of Giant Cell Arteritis
for
Giant Cell Arteritis
Location: New York NY, Montreal, Philadelphia PA, Toronto,
Sponsor: University of Pennsylvania
Sex: All
Age: 50+
Code: NCT04474847
Phase 3, Recruiting
Frailty Phenotype Assessments to Optimize Treatment Strategies for Older Patients With Hematologic Malignancies
for
Leukemia, Acute, MDS
Location: Philadelphia PA
Sponsor: Abramson Cancer Center at Penn Medicine
Sex: All
Age: 60+
Code: NCT03680677
Recruiting
A Study of Venoarterial ECMO vs Off-Pump Bilateral Orthotopic Lung Transplantation
for
Lung Transplant
Location: Philadelphia PA, Baltimore MD, Columbus OH,
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT05547698
Recruiting
Safety and Efficacy of AGN-INM176 in Prostate Patients With Rising PSA
for
Prostate Cancer
Location: Hershey PA
Sponsor: Milton S. Hershey Medical Center
Sex: Male
Age: 40+
Code: NCT06600698
Phase 1, Phase 2, Recruiting
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer